[go: up one dir, main page]

TR199802769T2 - Topical composition containing a combination of terpenoid compounds and antihistamine compounds. - Google Patents

Topical composition containing a combination of terpenoid compounds and antihistamine compounds.

Info

Publication number
TR199802769T2
TR199802769T2 TR1998/02769T TR9802769T TR199802769T2 TR 199802769 T2 TR199802769 T2 TR 199802769T2 TR 1998/02769 T TR1998/02769 T TR 1998/02769T TR 9802769 T TR9802769 T TR 9802769T TR 199802769 T2 TR199802769 T2 TR 199802769T2
Authority
TR
Turkey
Prior art keywords
compounds
antihistamine
combination
terpenoid
composition containing
Prior art date
Application number
TR1998/02769T
Other languages
Turkish (tr)
Inventor
Tschollar Werner
Schmid Beat
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of TR199802769T2 publication Critical patent/TR199802769T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Bulus, alerjik ve iltahabik deri hastaliklarinin tedavisi için bir terpenoid bilesik ile bir antihistaminik bilesigin bir karisimini ihtiva eden topikal eczasal bilesimlere oldugu kadar bir terpenoid bilesik (bir topikal ilacin imali için) ile kombinasyondaki bir antihistaminik bilesigin topikal kullanimina iliskindir.The invention relates to the topical use of an antihistamine compound in combination with a terpenoid compound (for the manufacture of a topical drug) as well as topical pharmaceutical compositions containing a mixture of a terpenoid compound and an antihistamine compound for the treatment of allergic and inflammatory skin diseases.

TR1998/02769T 1996-07-02 1997-07-01 Topical composition containing a combination of terpenoid compounds and antihistamine compounds. TR199802769T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810436 1996-07-02

Publications (1)

Publication Number Publication Date
TR199802769T2 true TR199802769T2 (en) 1999-04-21

Family

ID=8225640

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02769T TR199802769T2 (en) 1996-07-02 1997-07-01 Topical composition containing a combination of terpenoid compounds and antihistamine compounds.

Country Status (7)

Country Link
EP (1) EP0910410A1 (en)
JP (1) JP2000515498A (en)
AU (1) AU3440697A (en)
CA (1) CA2258513A1 (en)
TR (1) TR199802769T2 (en)
WO (1) WO1998000168A1 (en)
ZA (1) ZA975902B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE278017T1 (en) * 1998-04-21 2004-10-15 Max Planck Gesellschaft HUMAN K+ ION CHANNEL AND THERAPEUTIC USES THEREOF
DE69939019D1 (en) * 1998-07-07 2008-08-14 Transdermal Technologies Inc COMPOSITIONS FOR THE RAPID AND NON-IRRITANT TRANSDERMAL ADMINISTRATION OF PHARMACEUTICALS AND METHOD FOR FORMULING THEREOF AND THEIR ADMINISTRATION
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
DE60012610T2 (en) * 1999-04-22 2005-08-04 Shiseido Co. Ltd. Selective antibacterial compositions
CA2407657C (en) * 2000-05-09 2010-07-27 Unilever Plc Cosmetic skin care compositions containing pulegone
AU2002229611A1 (en) * 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
WO2002096870A2 (en) * 2001-05-31 2002-12-05 The Regents Of The University Of California Sponge-derived terpenoids and methods of use
US6720423B2 (en) 2002-04-30 2004-04-13 Allergan, Inc. Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
JP4614638B2 (en) * 2002-06-07 2011-01-19 第一三共株式会社 Analgesic composition
CN1809330B (en) * 2003-06-17 2010-10-13 Dsmip资产公司 Topical agents containing phytanic acid or a derivative thereof
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US20090264664A1 (en) * 2005-10-21 2009-10-22 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
CN101390830B (en) * 2008-11-12 2011-05-18 常州市第四制药厂有限公司 Anarexol cream and preparation method thereof
JP5912238B2 (en) * 2010-09-30 2016-04-27 小林製薬株式会社 Emulsified composition
PT2735309T (en) 2012-11-27 2016-09-26 Cos Alfonso Eduardo Pharmaceutical composition for the treatment of calcific tendinitis and/or calcific bursitis
ES2821793T3 (en) * 2013-02-01 2021-04-27 Ddrops Company Liquid menthol compositions
JP6537775B2 (en) * 2014-03-10 2019-07-03 小林製薬株式会社 Emulsified composition
WO2018063876A1 (en) * 2016-09-30 2018-04-05 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery systems comprising cetirizine dihydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122420A (en) * 1982-12-28 1984-07-14 Otsuka Pharmaceut Factory Inc Local ointment
ATE55905T1 (en) * 1984-03-07 1990-09-15 Roshdy Ismail MEANS FOR TREATMENT AND PROTECTION OF THE SKIN.
JPS62205019A (en) * 1986-03-03 1987-09-09 Kao Corp Drug for external use
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU4058689A (en) * 1988-06-24 1990-01-12 Stephen Herman Ozonides of terpenes and their medical uses
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
WO1992013540A1 (en) * 1991-02-06 1992-08-20 Guy Parent Antalgic ointment
JPH05286860A (en) * 1992-04-03 1993-11-02 Kowa Co Gel ointment
WO1994008550A1 (en) * 1992-10-09 1994-04-28 The Procter & Gamble Company Anaesthetic compositions

Also Published As

Publication number Publication date
EP0910410A1 (en) 1999-04-28
CA2258513A1 (en) 1998-01-08
WO1998000168A1 (en) 1998-01-08
ZA975902B (en) 1999-01-04
JP2000515498A (en) 2000-11-21
AU3440697A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
TR199802769T2 (en) Topical composition containing a combination of terpenoid compounds and antihistamine compounds.
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
ES2168737T3 (en) INHIBITORS OF NITRICO SINTASA OXIDE.
HUP0102521A2 (en) Antitumor agents comprising a stilbene derivative and a platinum coordination compound
SE0001899D0 (en) New compounds
IS4073A (en) New multifunctional drug for increased resistance
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
TR200103233T2 (en) New drug compositions on the basis of anticholinergic compounds and ß-mimetics.
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BR0108678A (en) New compounds
ES2063073T3 (en) KNOWN AND NEW SELECTED ARYLMETHYLENE DERIVATIVES OF THIAZOLIDINONES, IMIDAZOLIDINONES AND OXAZOLIDINONES USEFUL AS ANTI-ALLERGIC AGENTS AND ANTI-INFLAMMATORY AGENTS.
BR9712523A (en) New heterocyclyl-substituted pyrazole derivatives
SE9504661D0 (en) New compounds
AR012172A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANALOGS OF LACTACISTIN AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
MX9301136A (en) COMPOSITIONS CONTAINING PSYLLIUM.
BR9406363A (en) Pharmaceutical composition process for the preparation of the same use and process for the treatment of diseases related to gastric acid
BR0209689A (en) Use of hmg fragment as anti-inflammatory agent
BR0113643A (en) Guanidinobenzamides compounds as mc4-r agonists and their uses
ATE243196T1 (en) PIPERIDINE AND PYRROLIDINE
CO5160321A1 (en) NEW COMPOSITIONS OF TIPRANAVIR AND RITONAVIR
DK1167354T3 (en) Racemic hypersensitivity A
DE69713300D1 (en) BENZOPYRANE DERIVATIVES WITH LEUKOTRIA-ANTAGONISTIC EFFECT
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
TR200000737T2 (en) Substituted chroma derivatives.
TR200000153T2 (en) 6-azauracil derivatives that inhibit il-5.